Children with acute lymphoid leukemia are at moderate risk and generally have a better prognosis if they are treated in a timely manner; if they are not treated in a timely manner, it may lead to death.
The full name of acute lymphoblastic leukemia is acute lymphoblastic leukemia, which is the most common pediatric malignant tumor in China.
The most important treatment for acute lymphoblastic leukemia is chemotherapy, which is divided into three stages: induction therapy, consolidation therapy and prevention of extramedullary leukemia. Due to the continuous improvement of chemotherapy technology in recent years, acute lymphoblastic leukemia is no longer considered as a terminal disease. After treatment, the five-year survival rate of children is about 70% to 85%, so the prognosis is good, but the specific situation varies from person to person.
In addition to this, treatments include molecular targeted therapy, hematopoietic stem cell transplantation, and so on. It is recommended to seek timely medical treatment after detection.